Cargando…

Maternal plasma pro-atrial and C-type natriuretic peptide levels and their associations with cardiovascular and renal function in the second half of normal pregnancy: a longitudinal study

BACKGROUND: Physiological adaptation in pregnancy is characterized by remodeling of endocrine, cardiovascular and renal functions leading to fluid retention, volume expansion, altered cardiac loading conditions and hyperdynamic circulation. Natriuretic peptides have been used as biomarkers of cardio...

Descripción completa

Detalles Bibliográficos
Autores principales: Yarlagadda, Rima D., Johnson, Jonas, Vårtun, Åse, Flo, Kari, Acharya, Ganesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097896/
https://www.ncbi.nlm.nih.gov/pubmed/33952207
http://dx.doi.org/10.1186/s12884-021-03824-3
_version_ 1783688404901298176
author Yarlagadda, Rima D.
Johnson, Jonas
Vårtun, Åse
Flo, Kari
Acharya, Ganesh
author_facet Yarlagadda, Rima D.
Johnson, Jonas
Vårtun, Åse
Flo, Kari
Acharya, Ganesh
author_sort Yarlagadda, Rima D.
collection PubMed
description BACKGROUND: Physiological adaptation in pregnancy is characterized by remodeling of endocrine, cardiovascular and renal functions leading to fluid retention, volume expansion, altered cardiac loading conditions and hyperdynamic circulation. Natriuretic peptides have been used as biomarkers of cardiovascular function, but their associations with gestational age-related changes in maternal cardiac, endothelial and renal function have not been elucidated. The aim of this study was to establish longitudinal reference values for maternal plasma atrial natriuretic peptide (proANP) and C-type natriuretic peptide (CNP) and investigate their temporal association with cardiovascular and renal function in the second half of pregnancy. METHODS: This study was a prospective longitudinal study of 53 low-risk pregnancies. Women were examined every 3–5 weeks during 22–40 weeks of gestation (252 observations). Fasting maternal blood samples were obtained to measure proANP, CNP, creatinine, cystatin C, uric acid, and fibrinogen levels. Cardiac function and systemic hemodynamics were assessed noninvasively by impedance cardiography (ICG) and vascular endothelial function by flow-mediated vasodilation of brachial artery (FMD). RESULTS: The plasma proANP (R(2)adj = 0.79; P = 0.007), CNP (R2adj = 0.54; P = 0.005) decreased between 22 and 40 weeks. The creatinine (R(2)adj = 0.90; P < 0.001), cystatin C (R(2)adj = 0.93; P = < 0.001) and uric acid (R(2)adj = 0.83; P < 0.001) increased significantly, whereas the estimated glomerular filtration rate (R(2)adj = 0.93; P < 0.001) decreased with gestational age. The FMD did not change significantly but fibrinogen (R(2)adj = 0.79; P < 0.001) increased with advancing gestation. The maternal systemic vascular resistance index (R(2)adj = 0.50; P < 0.001) increased, stroke index (R(2)adj = 0.62; P < 0.001) decreased, whereas the cardiac index (R(2)adj = 0.62; P = 0.438) and thoracic fluid content (R(2)adj = 0.72; P = 0.132) did not change significantly with gestation. The proANP was associated with thoracic fluid content (R(2)adj = 0.74; P < 0.001) and fibrinogen (R(2)adj = 0.78; P = 0.034) but not with other variables of systemic hemodynamics, endothelial function, or renal function. The CNP was not associated significantly with parameters of cardiovascular or renal function. CONCLUSION: Longitudinal reference values for maternal plasma proANP and CNP were established. These natriuretic peptides decreased slightly with advancing gestation, but they did not reflect the temporal physiological changes in maternal systemic hemodynamics, vascular endothelial function and renal function during the second half of pregnancy. The proANP correlated with the thoracic fluid content reflecting volume load in pregnancy.
format Online
Article
Text
id pubmed-8097896
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80978962021-05-05 Maternal plasma pro-atrial and C-type natriuretic peptide levels and their associations with cardiovascular and renal function in the second half of normal pregnancy: a longitudinal study Yarlagadda, Rima D. Johnson, Jonas Vårtun, Åse Flo, Kari Acharya, Ganesh BMC Pregnancy Childbirth Research BACKGROUND: Physiological adaptation in pregnancy is characterized by remodeling of endocrine, cardiovascular and renal functions leading to fluid retention, volume expansion, altered cardiac loading conditions and hyperdynamic circulation. Natriuretic peptides have been used as biomarkers of cardiovascular function, but their associations with gestational age-related changes in maternal cardiac, endothelial and renal function have not been elucidated. The aim of this study was to establish longitudinal reference values for maternal plasma atrial natriuretic peptide (proANP) and C-type natriuretic peptide (CNP) and investigate their temporal association with cardiovascular and renal function in the second half of pregnancy. METHODS: This study was a prospective longitudinal study of 53 low-risk pregnancies. Women were examined every 3–5 weeks during 22–40 weeks of gestation (252 observations). Fasting maternal blood samples were obtained to measure proANP, CNP, creatinine, cystatin C, uric acid, and fibrinogen levels. Cardiac function and systemic hemodynamics were assessed noninvasively by impedance cardiography (ICG) and vascular endothelial function by flow-mediated vasodilation of brachial artery (FMD). RESULTS: The plasma proANP (R(2)adj = 0.79; P = 0.007), CNP (R2adj = 0.54; P = 0.005) decreased between 22 and 40 weeks. The creatinine (R(2)adj = 0.90; P < 0.001), cystatin C (R(2)adj = 0.93; P = < 0.001) and uric acid (R(2)adj = 0.83; P < 0.001) increased significantly, whereas the estimated glomerular filtration rate (R(2)adj = 0.93; P < 0.001) decreased with gestational age. The FMD did not change significantly but fibrinogen (R(2)adj = 0.79; P < 0.001) increased with advancing gestation. The maternal systemic vascular resistance index (R(2)adj = 0.50; P < 0.001) increased, stroke index (R(2)adj = 0.62; P < 0.001) decreased, whereas the cardiac index (R(2)adj = 0.62; P = 0.438) and thoracic fluid content (R(2)adj = 0.72; P = 0.132) did not change significantly with gestation. The proANP was associated with thoracic fluid content (R(2)adj = 0.74; P < 0.001) and fibrinogen (R(2)adj = 0.78; P = 0.034) but not with other variables of systemic hemodynamics, endothelial function, or renal function. The CNP was not associated significantly with parameters of cardiovascular or renal function. CONCLUSION: Longitudinal reference values for maternal plasma proANP and CNP were established. These natriuretic peptides decreased slightly with advancing gestation, but they did not reflect the temporal physiological changes in maternal systemic hemodynamics, vascular endothelial function and renal function during the second half of pregnancy. The proANP correlated with the thoracic fluid content reflecting volume load in pregnancy. BioMed Central 2021-05-05 /pmc/articles/PMC8097896/ /pubmed/33952207 http://dx.doi.org/10.1186/s12884-021-03824-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yarlagadda, Rima D.
Johnson, Jonas
Vårtun, Åse
Flo, Kari
Acharya, Ganesh
Maternal plasma pro-atrial and C-type natriuretic peptide levels and their associations with cardiovascular and renal function in the second half of normal pregnancy: a longitudinal study
title Maternal plasma pro-atrial and C-type natriuretic peptide levels and their associations with cardiovascular and renal function in the second half of normal pregnancy: a longitudinal study
title_full Maternal plasma pro-atrial and C-type natriuretic peptide levels and their associations with cardiovascular and renal function in the second half of normal pregnancy: a longitudinal study
title_fullStr Maternal plasma pro-atrial and C-type natriuretic peptide levels and their associations with cardiovascular and renal function in the second half of normal pregnancy: a longitudinal study
title_full_unstemmed Maternal plasma pro-atrial and C-type natriuretic peptide levels and their associations with cardiovascular and renal function in the second half of normal pregnancy: a longitudinal study
title_short Maternal plasma pro-atrial and C-type natriuretic peptide levels and their associations with cardiovascular and renal function in the second half of normal pregnancy: a longitudinal study
title_sort maternal plasma pro-atrial and c-type natriuretic peptide levels and their associations with cardiovascular and renal function in the second half of normal pregnancy: a longitudinal study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097896/
https://www.ncbi.nlm.nih.gov/pubmed/33952207
http://dx.doi.org/10.1186/s12884-021-03824-3
work_keys_str_mv AT yarlagaddarimad maternalplasmaproatrialandctypenatriureticpeptidelevelsandtheirassociationswithcardiovascularandrenalfunctioninthesecondhalfofnormalpregnancyalongitudinalstudy
AT johnsonjonas maternalplasmaproatrialandctypenatriureticpeptidelevelsandtheirassociationswithcardiovascularandrenalfunctioninthesecondhalfofnormalpregnancyalongitudinalstudy
AT vartunase maternalplasmaproatrialandctypenatriureticpeptidelevelsandtheirassociationswithcardiovascularandrenalfunctioninthesecondhalfofnormalpregnancyalongitudinalstudy
AT flokari maternalplasmaproatrialandctypenatriureticpeptidelevelsandtheirassociationswithcardiovascularandrenalfunctioninthesecondhalfofnormalpregnancyalongitudinalstudy
AT acharyaganesh maternalplasmaproatrialandctypenatriureticpeptidelevelsandtheirassociationswithcardiovascularandrenalfunctioninthesecondhalfofnormalpregnancyalongitudinalstudy